Clinical trials help advance our knowledge of new and current treatments. There are many clinical trials underway utilizing Cyclophosphamide as a potential remedy for Leukemia Fanconi Anemia, Lymphoma Mantle Cell Lymphoma, Fanconi Anemia and Acute Myeloid Leukemia. In Lansing that is located in the State of Michigan, 21 medical studies are researching the treatment Cyclophosphamide.
The following list has some of the active clinical trials for Cyclophosphamide:
- Pentostatin Cyclophosphamide and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
- Vincristine Dactinomycin and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
- Combination Chemotherapy Radiation Therapy and/or Surgery in Treating Patients With High-Risk Kidney Tumors
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Volunteers that participate in a clinical trial may benefit from treatments that have not yet reached the market. You may also be eligible for free medical care if you enroll in one of these active Cyclophosphamide clinical trials.